Table 1

Categories of baseline characteristics and mean PTH concentration (SD)

CharacteristicPTH concentration (pg/ml)
N* (%)Mean (SD)p Value (Satterthwaite t-test/Welch ANOVA)
Total cohort1133 (100)37.3 (18.6)
Gender
 Female176 (15.5)39.5 (20.6)0.12
 Male957 (84.5)36.9 (18.2)
Age at baseline (years)
 30–49173 (15.3)33.0 (14.1)<0.0001
 50–59332 (29.3)36.6 (17.9)
 ≥60628 (55.4)38.8 (19.9)
Duration of school education (years)
 <10 (basic education)677 (60.1)37.0 (19.8)0.61
 ≥10 (higher education)449 (39.9)37.6 (16.8)
Family status
 Other200 (17.7)37.8 (16.5)0.63
 Married932 (82.3)37.2 (19.1)
History of smoking
 Never-smoker349 (30.8)38.5 (20.7)0.39
 Ex-smoker721 (63.6)36.7 (17.9)
 Current smoker63 (5.6)37.1 (13.8)
Body mass index (kg/m2)
 <25303 (26.8)37.8 (17.5)0.08
 25–30654 (57.8)36.1 (17.0)
 >30175 (15.5)40.1 (23.7)
History of diabetes
 No924 (82.2)37.2 (17.9)0.93
 Yes200 (17.8)37.3 (21.8)
History of hypertension
 No504 (44.8)34.7 (16.1)<0.0001
 Yes622 (55.2)39.3 (20.2)
Treatment with diuretics
 No854 (75.6)35.0 (14.3)<0.0001
 Yes276 (24.4)44.6 (26.9)
Treatment with aspirin
 No142 (12.6)41.1 (22.2)0.03
 Yes988 (87.4)36.7 (18.0)
Treatment with ACE inhibitors
 No524 (46.4)36.2 (17.7)0.07
 Yes606 (53.6)38.2 (19.4)
Treatment with β-blockers
 No151 (13.4)37.9 (18.2)0.65
 Yes979 (86.6)37.2 (18.7)
Treatment with lipid-lowering drugs
 No260 (23.0)40.2 (21.0)0.009
 Yes870 (77.0)36.4 (17.8)
Treatment with calcium antagonists
 No1033 (91.4)37.3 (18.8)0.86
 Yes97 (8.6)37.6 (16.6)
No of affected vessels
 0–1293 (27.3)35.2 (15.0)0.06
 2303 (28.2)37.6 (17.8)
 3–4479 (44.6)38.1 (20.8)
Ventricular function
 No to mild impairment808 (78.0)36.1 (17.3)<0.0001
 Moderate to severe impairment228 (22.0)42.8 (23.6)
Season of blood draw§
 Spring435 (38.7)39.6 (20.1)<0.0001
 Summer249 (22.2)36.3 (15.4)
 Autumn207 (18.4)30.3 (17.2)
 Winter233 (20.7)40.4 (18.9)
  • * Numbers do not always add up to 1133 due to missing values.

  • Percentage of non-missing values.

  • Determined by angiography or echocardiography.

  • § Spring (March–May), summer (June–August), autumn (September–November), winter (December–February).

  • PTH, parathyroid hormone.